2014
DOI: 10.1111/ceo.12308
|View full text |Cite
|
Sign up to set email alerts
|

Retinoic acid receptor stimulation ameliorates experimental autoimmune optic neuritis

Abstract: These findings demonstrate that all-trans retinoic acid and Am80 treatment were able to reduce the severity of optic neuritis in mice with experimental autoimmune encephalomyelitis. Activation of retinoic acid receptor-α/β may be a molecular target for the treatment of autoimmune optic neuritis induced by Th1 or Th17-dominated immune responses.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2015
2015
2017
2017

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 29 publications
1
0
0
Order By: Relevance
“…3 ). Although the outcome of specific RARβ activation in human CNS was unclear, activation RAR α/β with ATRA might ameliorate remyelination in experimental autoimmune encephalomyelitis mouse for 22 days [26] , which was agree to our result that two important transcriptional regulators Hes5 and Id4 were reduced at 27 day after exposure to ATRA. However, longer duration of exposure to ATRA might cause more induction of negative regulators ( Fig.…”
Section: Discussionsupporting
confidence: 92%
“…3 ). Although the outcome of specific RARβ activation in human CNS was unclear, activation RAR α/β with ATRA might ameliorate remyelination in experimental autoimmune encephalomyelitis mouse for 22 days [26] , which was agree to our result that two important transcriptional regulators Hes5 and Id4 were reduced at 27 day after exposure to ATRA. However, longer duration of exposure to ATRA might cause more induction of negative regulators ( Fig.…”
Section: Discussionsupporting
confidence: 92%